GlassScriptPhysician profile
Trevor J Johnson
NPI 1023501707
$10,526.22
in general payments reported to CMS, 2019-2025
17 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $4,855 · 2024: $4,669 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,829 · Food and Beverage: $2,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,829.42 |
| Food and Beverage | $2,696.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,207.87 | 2023-2024 | Proclaim, Eterna |
| Stryker Corporation | $1,854.81 | 2024-2025 | Spinejack, Optablate, Mild Device Kit |
| Surgentec | $1,208.77 | 2024 | Tilink, Ion |
| Spinal Simplicity, LLC | $1,129.99 | 2024 | Ha Minuteman G3-R |
| Stratus Medical, LLC | $343.87 | 2024-2025 | Nimbus |
| Spr Therapeutics, INC | $173.77 | 2024-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $165.79 | 2024-2025 | Belbuca |
| Saluda Medical Americas, INC. | $124.50 | 2025 | Evoke |
| Nevro Corp. | $83.37 | 2024 | Senza, Vyrsa V1 |
| Boston Scientific Corporation | $66.56 | 2024 | |
| Biotronik Nro, INC. | $42.25 | 2025 | Prospera |
| Abbvie INC. | $39.02 | 2025 | |
| Medtronic, INC. | $21.29 | 2025 | Kyphon Express II Kyphopak Tray |
| Hydrocision, INC. | $19.96 | 2025 | Tenjet |
| Globus Medical, INC. | $15.73 | 2025 | Senza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $14.78 | 2025 | |
| Scilex Pharmaceuticals INC. | $13.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.